ArticleScientific reports2025

Idarucizumab more effectively reverses the anticoagulant effects of dabigatran acylglucuronide than dabigatran.

Jong-Min Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.